Objectives To test reproducibility and predictive value of a simplified score for assessment of extraprostatic tumor extension (sEPE grade). Methods Sixty-five patients (mean age & PLUSMN; SD, 67 years & PLUSMN; 6.3) treated with radical prostatectomy for prostate cancer who underwent 1.5-Tesla multiparametric magnetic resonance imaging (mpMRI) 6 months before surgery were enrolled. sEPE grade was derived from mpMRI metrics: curvilinear contact length > 15 mm (CCL) and capsular bulging/irregularity. The diameter of the index lesion (dIL) was also measured. Evaluations were independently performed by seven radiologists, and inter-reader agreement was tested by weighted Cohen K coefficient. A nested (two levels) Monte Carlo cross-validation was used. The best cut-off value for dIL was selected by means of the Youden J index to classify values into a binary variable termed dIL*. Logistic regression models based on sEPE grade, dIL, and clinical scores were developed to predict pathologic EPE. Results on validation set were assessed by the main metrics of the receiver operating characteristics curve (ROC) and by decision curve analysis (DCA). Based on our findings, we defined and tested an alternative sEPE grade formulation. Results Pathologic EPE was found in 31/65 (48%) patients. Average kappa(w) was 0.65 (95% CI 0.51-0.79), 0.66 (95% CI 0.48-0.84), 0.67 (95% CI 0.50-0.84), and 0.43 (95% CI 0.22-0.63) for sEPE grading, CLL & GE; 15 mm, dIL*, and capsular bulging/irregularity, respectively. The highest diagnostic yield in predicting EPE was obtained by combining both sEPE grade and dIL*(ROC-AUC 0.81). Conclusions sEPE grade is reproducible and when combined with the dIL* accurately predicts extraprostatic tumor extension.
MR-based simplified extraprostatic extension evaluation: comparison of performances of different predictive models / Schiro, S.; Milanese, G.; Maddalo, M.; Ziglioli, F.; Maestroni, U. V.; Manna, C.; Ledda, R. E.; Negrini, G.; Mastrapasqua, F.; Cobelli, R.; Tamburino, G.; Conti, M. E.; Luceri, S.; Leo, L.; Ghetti, C.; Sverzellati, N.. - In: EUROPEAN RADIOLOGY. - ISSN 1432-1084. - 33:4(2023), pp. 2975-2984. [10.1007/s00330-022-09240-1]
MR-based simplified extraprostatic extension evaluation: comparison of performances of different predictive models
Milanese G.;Ziglioli F.;Maestroni U. V.;Manna C.;Ledda R. E.;Negrini G.;Mastrapasqua F.;Cobelli R.;Leo L.;Sverzellati N.
2023-01-01
Abstract
Objectives To test reproducibility and predictive value of a simplified score for assessment of extraprostatic tumor extension (sEPE grade). Methods Sixty-five patients (mean age & PLUSMN; SD, 67 years & PLUSMN; 6.3) treated with radical prostatectomy for prostate cancer who underwent 1.5-Tesla multiparametric magnetic resonance imaging (mpMRI) 6 months before surgery were enrolled. sEPE grade was derived from mpMRI metrics: curvilinear contact length > 15 mm (CCL) and capsular bulging/irregularity. The diameter of the index lesion (dIL) was also measured. Evaluations were independently performed by seven radiologists, and inter-reader agreement was tested by weighted Cohen K coefficient. A nested (two levels) Monte Carlo cross-validation was used. The best cut-off value for dIL was selected by means of the Youden J index to classify values into a binary variable termed dIL*. Logistic regression models based on sEPE grade, dIL, and clinical scores were developed to predict pathologic EPE. Results on validation set were assessed by the main metrics of the receiver operating characteristics curve (ROC) and by decision curve analysis (DCA). Based on our findings, we defined and tested an alternative sEPE grade formulation. Results Pathologic EPE was found in 31/65 (48%) patients. Average kappa(w) was 0.65 (95% CI 0.51-0.79), 0.66 (95% CI 0.48-0.84), 0.67 (95% CI 0.50-0.84), and 0.43 (95% CI 0.22-0.63) for sEPE grading, CLL & GE; 15 mm, dIL*, and capsular bulging/irregularity, respectively. The highest diagnostic yield in predicting EPE was obtained by combining both sEPE grade and dIL*(ROC-AUC 0.81). Conclusions sEPE grade is reproducible and when combined with the dIL* accurately predicts extraprostatic tumor extension.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
